Evidence map›Paper›PMID 37067472›Full record

ArticleJournal of AOAC International2023

Amplicon Sequencing Minimal Information (ASqMI): Quality and Reporting Guidelines for Actionable Calls in Biodefense Applications.

Ishi Keenum, Robert Player, Jason Kralj, Stephanie Servetas, Michael D Sussman, Joseph A Russell, Jennifer Stone, Sailaja Chandrapati, Shanmuga Sozhamannan

Open access · hybridAbstract read
In one paragraph

Article in Journal of AOAC International, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ishi KeenumNational Institute of Standards and Technology, Biosystems and Biomaterials Division, Complex Microbial Systems Group, Gaithersburg, MD 20899, USA.ORCID 0000-0002-5441-4634
Robert PlayerThe Johns Hopkins University, Applied Physics Laboratory, Laurel, MD 20723, USA.ORCID 0000-0001-5872-259X
Jason KraljNational Institute of Standards and Technology, Biosystems and Biomaterials Division, Complex Microbial Systems Group, Gaithersburg, MD 20899, USA.ORCID 0000-0003-4565-1176
Stephanie ServetasNational Institute of Standards and Technology, Biosystems and Biomaterials Division, Complex Microbial Systems Group, Gaithersburg, MD 20899, USA.ORCID 0000-0002-4924-4511
Michael D SussmanUS Department of Agriculture, Agricultural Analytics Division, Livestock and Poultry Programs, Agricultural Marketing Service, Washington, DC 20250 USA.ORCID 0000-0002-8432-0487
Joseph A RussellMRIGlobal, Gaithersburg, MD 20878, USA.ORCID 0000-0002-0623-5519
Jennifer StoneMRIGlobal, Gaithersburg, MD 20878, USA.ORCID 0000-0002-1322-7760
Sailaja ChandrapatiNeogen Food Safety, Maplewood, MN 55125, USA.ORCID 0000-0002-8069-5468
Shanmuga SozhamannanJoint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB), Frederick, MD 21702, USA.ORCID 0000-0002-6762-7874
National Institute of Standards and Technology · USMRIGlobal · USAgricultural Marketing Service · USCenter for Food Safety and Applied Nutrition · USJohns Hopkins University Applied Physics Laboratory · US

Funding

Defense Biological Product Assurance OfficeDepartment of DefenseDeputy Under Secretary of the ArmyJoint Program Executive OfficeJoint Project Lead-Enabling BiotechnologiesTest and Evaluation
6 · The paper itself

Abstract

backgroundAccurate, high-confidence data is critical for assessing potential biothreat incidents. In a biothreat event, false-negative and -positive results have serious consequences. Worst case scenarios can result in unnecessary shutdowns or fatalities at an exorbitant monetary and psychological cost, respectively. Quantitative PCR assays for agents of interest have been successfully used for routine biosurveillance. Recently, there has been increased impetus for adoption of amplicon sequencing (AS) for biosurveillance because it enables discrimination of true positives from near-neighbor false positives, as well as broad, simultaneous detection of many targets in many pathogens in a high-throughput scheme. However, the high sensitivity of AS can lead to false positives. Appropriate controls and workflow reporting can help address these challenges.

objectivesData reporting standards are critical to data trustworthiness. The standards presented herein aim to provide a framework for method quality assessment in biodetection.

methodsWe present a set of standards, Amplicon Sequencing Minimal Information (ASqMI), developed under the auspices of the AOAC INTERNATIONAL Stakeholder Program on Agent Detection Assays for making actionable calls in biosurveillance applications. In addition to the first minimum information guidelines for AS, we provide a controls checklist and scoring scheme to assure AS run quality and assess potential sample contamination.

resultsAdoption of the ASqMI guidelines will improve data quality, help track workflow performance, and ultimately provide decision makers confidence to trust the results of this new and powerful technology.

conclusionAS workflows can provide robust, confident calls for biodetection; however, due diligence in reporting and controls are needed. The ASqMI guideline is the first AS minimum reporting guidance document that also provides the means for end users to evaluate their workflows to improve confidence. HIGHLIGHTS: Standardized reporting guidance for actionable calls is critical to ensuring trustworthy data.

Indexed as

Research DesignPolymerase Chain Reaction

Identifiers

PMID37067472
PMCPMC10472743
OpenAlexW4366082783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.